Glioblastoma is a highly aggressive central nervous system neoplasm characterized by extensive infiltration of malignant cells into brain parenchyma, thus preventing complete tumor eradication. Cysteine cathepsins B, S, L and K are involved in cancer progression and are overexpressed in glioblastoma. We report here for the first time that cathepsin X mRNA and protein are also abundantly present in malignant glioma
A b s t r a c t Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (A...
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor patient survival that is at ...
International audienceCathepsin L, a cysteine protease, is overexpressed in human tumor cells and pl...
Glioblastoma is a highly aggressive central nervous system neoplasm characterized by extensive infil...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
Glioblastoma (GBM) is the most lethal brain tumor also due to malignant and therapy-resistant GBM st...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
<div><p>Background</p><p>Cancer genome and transcriptome analyses advanced our understanding of canc...
Treatment of glioblastoma (GBM) remains very challenging, and it is particularly important to find s...
Background: Gliomas are the most common primary malignant brain tumor and these are among the most c...
Brain gliomas constitute the vast majority of malignant tumors of the nervous system. There is still...
Invasion and metastasis of certain tumors are accompanied by increased mRNA protein levels and enzym...
Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (ASPS) and a subs...
Objectives: Cathepsin K, a lysosomal cysteine protease, is expressed in the tumor microenvironment (...
A b s t r a c t Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (A...
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor patient survival that is at ...
International audienceCathepsin L, a cysteine protease, is overexpressed in human tumor cells and pl...
Glioblastoma is a highly aggressive central nervous system neoplasm characterized by extensive infil...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
Glioblastoma (GBM) is the most lethal brain tumor also due to malignant and therapy-resistant GBM st...
Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed ...
<div><p>Background</p><p>Cancer genome and transcriptome analyses advanced our understanding of canc...
Treatment of glioblastoma (GBM) remains very challenging, and it is particularly important to find s...
Background: Gliomas are the most common primary malignant brain tumor and these are among the most c...
Brain gliomas constitute the vast majority of malignant tumors of the nervous system. There is still...
Invasion and metastasis of certain tumors are accompanied by increased mRNA protein levels and enzym...
Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (ASPS) and a subs...
Objectives: Cathepsin K, a lysosomal cysteine protease, is expressed in the tumor microenvironment (...
A b s t r a c t Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (A...
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor patient survival that is at ...
International audienceCathepsin L, a cysteine protease, is overexpressed in human tumor cells and pl...